The University of Oslo, in collaboration with Oslo University Hospital, seeks to establish advanced Explore-HT proteomics assays from Olink Proteomics AB at Ullevål Hospital. This acquisition is essential to ensure that the assays are conducted with the highest level of accuracy and efficiency. In order to achieve this, four specific instruments, as recommended by Olink Proteomics, are required. These instruments have been rigorously validated to meet Olink’s protocols and are critical for the success of this project.
Suppliers are requested to log in to TendSign to access all relevant documents for this case, which provide comprehensive justification. Alternatively, they may contact case handler at murtezam@admin.uio.no for more information.